Filters close
Newswise: Cell Division, DNA Repair, and Cancer Progression Closely Tied to CDK9 Dysfunction
1-Mar-2024 10:05 AM EST
Cell Division, DNA Repair, and Cancer Progression Closely Tied to CDK9 Dysfunction
Sbarro Health Research Organization (SHRO)

Researchers describe a newly-observed role for the protein Cyclin Dependent Kinase 9 (CDK9) in regulating DNA repair during cellular division, where errors can become the origin of cancerous tumor growth.

Newswise: Star of Mother Cabrini Biopic Visits Sbarro Health Research Organization On Premier of Film
Released: 22-Feb-2024 12:05 PM EST
Star of Mother Cabrini Biopic Visits Sbarro Health Research Organization On Premier of Film
Sbarro Health Research Organization (SHRO)

Cristiana Della’Anna, the actress who portrays Mother Cabrini in the upcoming biopic, Cabrini, visits with Sbarro Health Research Organization Founder and President Antonio Giordano

   
Newswise: The Filangieri-Franklin Correspondence: An Enlightening Dialogue Between Italy and the USA - A Talk at the University of Pennsylvania
Released: 14-Nov-2023 3:05 PM EST
The Filangieri-Franklin Correspondence: An Enlightening Dialogue Between Italy and the USA - A Talk at the University of Pennsylvania
Sbarro Health Research Organization (SHRO)

Talk on the Filangieri-Franklin Correspondence will be held at the University of Pennsylvania on November 16, 2023.

Released: 2-Nov-2023 5:05 PM EDT
Dexamethasone Implants Could Preserve Vision Longer for Diabetic Macular Edema Patients
Sbarro Health Research Organization (SHRO)

Diabetic macular edema (DME) is a significant complication of diabetes, often leading to vision loss. A recent review paper published in the journal Pharmaceutics provides evidence-based recommendations on using intravitreal dexamethasone implants (DEX) for treating DME.

Released: 12-Oct-2023 5:05 AM EDT
AI Discussion at International Medical Conference Presented by Sbarro Health Research Organization
Sbarro Health Research Organization (SHRO)

Top Italian Scientists join the discussion of AI and Machine Learning presented by the Sbarro Health Research Organization (SHRO) in collaboration with the National Italian American Foundation (NIA) this weekend at the annual NIAF convention and gala.

Newswise: Blood Thinners Have Role in Cancer Care to Prevent Embolism
Released: 12-Sep-2023 11:25 AM EDT
Blood Thinners Have Role in Cancer Care to Prevent Embolism
Sbarro Health Research Organization (SHRO)

Analysis of anticoagulants in patients with malignant cancer shows that further study is needed to establish an adjuvant, or combined, treatment protocol.

Newswise: IMG_1376.jpeg
Released: 24-Aug-2023 2:05 PM EDT
Virtual Reality Study Reveals Link Between Sense of Presence and Cognitive Abilities
Sbarro Health Research Organization (SHRO)

A groundbreaking study published in *Scientific Reports, a Nature portfolio scientific journal, has shed light on the intricate relationship between the sense of presence in virtual reality (VR) environments and cognitive abilities.

Released: 12-Jul-2023 8:20 AM EDT
Deeper Understanding of Malignant Mesothelioma Reveals New Novel Targets to Investigate
Sbarro Health Research Organization (SHRO)

Progranulin is a growth factor in cellular activity that is known to play a key role in the proliferation of tumors. In the case of malignant mesothelioma, researchers are honing in on how progranulin interacts with signal pathways through a system of proteins and receptors in our cells.

Released: 14-Jun-2023 10:00 AM EDT
Genetic Oncology Conference Hosted by SHRO at Temple University Connecting Students and Researchers
Sbarro Health Research Organization (SHRO)

Scientific discoveries on Hereditary Cancer Syndromes have evolved in recent years, with advances in understanding the genetic basis of various tumors and the biological underpinnings of inherited cancer syndromes.

Newswise: Barriers to Breast Cancer-Screening in Vulnerable Populations
Released: 6-Jun-2023 1:15 PM EDT
Barriers to Breast Cancer-Screening in Vulnerable Populations
Sbarro Health Research Organization (SHRO)

Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.

Released: 22-May-2023 8:00 AM EDT
Therapy Animals and a Review of the Risk for Zoonotic Transmission
Sbarro Health Research Organization (SHRO)

Animal-Assisted interventions (AAI) are implemented in hospitals and rehabilitation centers to produce many advantages for the patients but could expose them to pathogens transmission, a process known as zoonosis.

Released: 18-May-2023 8:25 AM EDT
Researchers Target Commonly Mutated or Deleted Gene in Gynecological Cancers
Sbarro Health Research Organization (SHRO)

A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers.

Newswise: Antonio Giordano, M.D., Ph.D. Honored with da Vinci Award by the Italian Heritage and Culture Committee of New York
Released: 27-Apr-2023 11:35 AM EDT
Antonio Giordano, M.D., Ph.D. Honored with da Vinci Award by the Italian Heritage and Culture Committee of New York
Sbarro Health Research Organization (SHRO)

Members of the Board of Directors of the Italian Heritage and Culture Committee-NY, Inc. (IHCC-NY) honored Dr. Antonio Giordano, Founder and Director of the Sbarro Health Research Organization (SHRO) on April 24, 2023, with its coveted Leonardo da Vinci award, awarded annually by the 47-year-old cultural organization.

Released: 30-Mar-2023 4:15 PM EDT
New Review Reveals the Critical Role of Progranulin in Cancer
Sbarro Health Research Organization (SHRO)

A recent review paper published in the journal Cancers highlights the important role of the growth factor progranulin in the initiation and progression of cancer.

Newswise: Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO
Released: 29-Mar-2023 3:30 PM EDT
Top US and Italian Researchers Unite for Cutting-Edge Conference on Medicine, Science, and Technology Hosted by SHRO
Sbarro Health Research Organization (SHRO)

The Sbarro Health Research Organization (SHRO), led by Prof. Antonio Giordano, in collaboration with the Texas Scientific Italian Community (TSIC), led by Prof. Andrea Giuffrida, will present the XVII Conference of Italian Researchers in the World on Saturday April 1st from 9:30 AM to 3:00 PM at Temple University of Philadelphia.

   
Released: 6-Mar-2023 6:05 PM EST
SHRO's Giordano to Speak at Virtual Workshop on Artificial Intelligence in Medicine
Sbarro Health Research Organization (SHRO)

Artificial Intelligence and NGS Integrated into the Next Generation Tissue Microarrays (TMA) Workshop

Newswise: Cancer: In Italy every year over 8000 patients candidate for liquid biopsy
Released: 21-Feb-2023 10:10 PM EST
Cancer: In Italy every year over 8000 patients candidate for liquid biopsy
Sbarro Health Research Organization (SHRO)

SHRO Founder Antonio Giordano contributes to a new publication on the use of liquid biopsy to assess the treatment response and find mutations that confer resistance to cancer therapies.

Newswise: Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
Released: 23-Jan-2023 11:05 AM EST
Malfunctioning Mitochondria at the Heart of Many Cardiovascular Diseases
Sbarro Health Research Organization (SHRO)

Many cardiovascular diseases, such as atherosclerosis, or ‘hardening of the arteries,’ correlate to mitochondrial dysfunction and endothelial impairment in the tissues of the heart and blood vessels.

Released: 21-Dec-2022 10:50 AM EST
Are the Benefits of New Cancer Drugs Worth the Cost?
Sbarro Health Research Organization (SHRO)

An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743).

Released: 28-Nov-2022 9:00 AM EST
Links Between Neurological Involvement and Respiratory Damage in SARS-CoV-2 Infection
Sbarro Health Research Organization (SHRO)

Researchers working with Sbarro Health Research Organization (SHRO) have published a paper examining the possible links between neurological involvement and respiratory damage due to COVID-19.

Newswise:Video Embedded shro-medical-conference-plus-honorees-from-entertainment-business-and-politics-headlining-the-niaf-47th-annual-gala
VIDEO
Released: 28-Oct-2022 10:35 AM EDT
SHRO Medical Conference, Plus Honorees from Entertainment, Business, and Politics Headlining the NIAF 47th Annual Gala
Sbarro Health Research Organization (SHRO)

The National Italian American Foundation (NIAF) will celebrate its 47th Anniversary Gala at the elegant Omni Shoreham Hotel in Washington, D.C., on Saturday, October 29, 2022.

Newswise: Cellular Cilium an Early Sign of Mesothelioma Differentiation
Released: 26-Oct-2022 11:00 PM EDT
Cellular Cilium an Early Sign of Mesothelioma Differentiation
Sbarro Health Research Organization (SHRO)

A new study investigated the expression of the primary cilium in mesothelioma, finding that primary cilia is preferentially lost in the more aggressive subtype of mesothelioma and further research may confirm its potential prognostic and diagnostic value.

Newswise: Medical Conference: Italian and American Perspectives on Cancer Care
Released: 21-Oct-2022 4:05 PM EDT
Medical Conference: Italian and American Perspectives on Cancer Care
Sbarro Health Research Organization (SHRO)

The Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation will host the Medical Conference titled “Italian and American Perspectives on Cancer Care” on Saturday October 29th at 9:00 AM at the Omni Shoreham Hotel in Washington, DC.

Newswise: Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Released: 11-Oct-2022 4:20 PM EDT
Adverse Events Linked to PD-1 Blockade in Some Lung Cancer Patients
Sbarro Health Research Organization (SHRO)

Treatments with PD-1/PD-L1 immuno-checkpoint inhibitors are potentially related to adverse events in patients with metastatic Non-Small-Cell-Lung Cancer (mNSCLC).

Released: 27-Sep-2022 8:05 AM EDT
SHRO’s Giordano Participates in Lecture with Historic Tradition
Sbarro Health Research Organization (SHRO)

This week, Sbarro Health Research Organization (SHRO) Founder and President, Antonio Giordano, M.D., Ph.D., participates in a lecture sponsored by UC Berkeley’s Institute for European Studies.

   
Released: 14-Sep-2022 2:05 PM EDT
Predicting Outcomes for Rare Form of Bladder Cancer with Metastatic Tumors
Sbarro Health Research Organization (SHRO)

Upper tract urothelial carcinoma (UTUC) is a rare malignancy accounting for 5-10% of all urothelial cancers. When considering metastatic upper tract urothelial carcinoma (mUTUC) existing data is still limited.

Released: 30-Aug-2022 4:45 PM EDT
Molecular Medicine Review Reveals the Role of IGF in Cancer, Other Proliferative Disease
Sbarro Health Research Organization (SHRO)

Studies suggest that Insulin-Like Growth Factor (IGF) plays a central role in pathological growth of proliferative conditions like cancer, and may function as a resistance mechanism adopted by the majority of solid cancers following therapeutic targeting of non-IGF signaling pathways.

Released: 18-Aug-2022 12:00 PM EDT
Is It Still Worth Attending a University?
Sbarro Health Research Organization (SHRO)

In recent years, cultural and academic education has been disproportionately influenced by the concept of “competence,” at the expense of pursuing a well-rounded, liberal arts foundation.

Newswise: Immunotherapy Covered in Special Edition of Current Clinical Pathology
Released: 18-Aug-2022 9:00 AM EDT
Immunotherapy Covered in Special Edition of Current Clinical Pathology
Sbarro Health Research Organization (SHRO)

In the latest Current Clinical Pathology publication on Immunotherapy, Sbarro Health Research Organization (SHRO) President, Antonio Giordano, M.D., Ph.D., co-edits the volume, focused on cardiovascular toxicities.

Released: 6-Jul-2022 5:05 PM EDT
‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers
Sbarro Health Research Organization (SHRO)

A multi-disciplinary, “One Health” approach to cancer research is necessary to guide society in reduction of toxic substances, as well as regulation of chemical impacts on the environment and public health, according to an editorial published recently in Issue II of Annals of Research in Oncology.

Released: 6-Jul-2022 3:45 PM EDT
VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review
Sbarro Health Research Organization (SHRO)

Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.

Released: 28-Jun-2022 9:00 AM EDT
Drug Repurposing Identifies New Candidates to Treat Mesothelioma
Sbarro Health Research Organization (SHRO)

A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).

Released: 27-Jun-2022 3:00 PM EDT
Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology
Sbarro Health Research Organization (SHRO)

There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.

Released: 9-May-2022 1:30 PM EDT
Public Health Conference: 2022 Theme: Response to COVID-19 and Impact of the Pandemic
Sbarro Health Research Organization (SHRO)

Public Health conference hosted by Temple University Rome and Temple College of Public Health.

Released: 6-May-2022 10:35 AM EDT
Targeting Cervical Cancer Stem Cells to Improve Outcomes
Sbarro Health Research Organization (SHRO)

The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.

Released: 10-Mar-2022 6:05 AM EST
New Mesothelioma Drugs, Once Hailed as Gamechangers, Don’t Live Up to the Hype
Sbarro Health Research Organization (SHRO)

Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mostly related to asbestos exposure whose incidence is constantly rising, especially in low-income countries.

27-Dec-2021 5:05 PM EST
Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow
Sbarro Health Research Organization (SHRO)

Recently approved drugs to boost the immune response against cancer represents a novelty that should not be over-hyped, researchers say

Released: 17-Dec-2021 2:15 PM EST
No more doubts: e-cigs are less toxic than traditional cigarettes.
Sbarro Health Research Organization (SHRO)

Researchers demonstrate lower toxicity of nicotine-releasing electronic devices.

Released: 3-Dec-2021 2:50 PM EST
Age-Related Differences in Inflammation May Shed Light on the Limit of Immunotherapies
Sbarro Health Research Organization (SHRO)

Scientists at the Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, located at Temple University’s College of Science and Technology, working with collaborators in Italy, have described the age-related differences in inflammatory response to an emerging immunotherapy treatment for Non-Small-Cell Lung Cancer (NSCLC) called PD-1 blockade.

Released: 30-Nov-2021 1:35 PM EST
Single-cell sequencing and bioinformatic tools applications discussed in Research Review
Sbarro Health Research Organization (SHRO)

Nowadays, single-cell RNA sequencing technologies and related bioinformatics tools are emerging as essential devices for dissecting tumors at single-cell resolution and understanding carcinogenesis and drug response mechanisms, representing a turning point in cancer research.

Released: 23-Nov-2021 10:10 AM EST
Tumor Blood Vessel Growth May Be Target to Treat Glioblastoma and Other Cancers
Sbarro Health Research Organization (SHRO)

A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.

Released: 5-Nov-2021 2:55 PM EDT
SHRO’s Giordano Meets with Appropriations Committee Chair on Capitol Hill
Sbarro Health Research Organization (SHRO)

Professor Antonio Giordano, M.D., Ph.D., Neapolitan Oncologist, Director of the Sbarro Institute for Cancer Research at Temple University and founder of the Sbarro Health Research Organization (SHRO), met today with Congresswoman Rosa DeLauro (D-CT), Chair of the House Appropriations Committee, at the Rayburn House Office Building on Capitol Hill.

Released: 4-Nov-2021 10:30 AM EDT
Research Supports More Effective Choices Than Ever for Drug-Free Pain Relief During Labor and Delivery
Sbarro Health Research Organization (SHRO)

Researchers coordinated by Professor Antonio Giordano, M.D., Ph.D., Founder and Director of the Sbarro Health Research Organization (SHRO) have highlighted the effectiveness of non-pharmacological analgesic techniques during childbirth in a review recently published in the journal Eukaryotic Gene Expression.

Newswise: National Italian American Foundation Awards Fauci Scholarships at Annual Gala
Released: 28-Oct-2021 9:00 AM EDT
National Italian American Foundation Awards Fauci Scholarships at Annual Gala
Sbarro Health Research Organization (SHRO)

NIAF Board Member and SHRO Director Antonio Giordano leads scholarship committee.

Released: 25-Aug-2021 5:30 PM EDT
Fungal and Bacterial Biodeterioration of Outdoor Canvas Paintings: The Case of the Cloisters of Quito, Ecuador
Sbarro Health Research Organization (SHRO)

The journal Critical Review In Eukaryotic Gene Expression has just published an interesting article entitled: “Fungal And Bacterial Biodeterioration Of Outdoor Canvas Paintings: The Case Of The Cloisters Of Quito, Ecuador.”

Released: 20-Aug-2021 2:45 PM EDT
GYNOCARE COST Creates International Research Collab on Rare Cancers Affecting Millions of Women Annually
Sbarro Health Research Organization (SHRO)

Sbarro Health Research Organization (SHRO) Founder and Director, Antonio Giordano, M.D., Ph.D., of Temple University and the University of Siena, Italy, is part of the GYNOCARE COST Action (CA18117) chaired by Prof Jean Calleja Agius of the University of Malta.

Released: 13-Aug-2021 4:20 PM EDT
An Emerging Clue to Cancer Therapy: Radiotherapy-Induced Autophagy May Enhance Modulation of Cell Cycle
Sbarro Health Research Organization (SHRO)

Building on prior success combining Cyclin-Dependent Kinase (CDK) inhibitors with hormone therapy to treat breast cancer, researchers are now exploring the potential integration of CDK inhibitors with radiotherapy in a paper issued in the International Journal of Molecular Sciences.

Released: 10-Aug-2021 10:30 AM EDT
Human-Dog Relationship during the First COVID-19 Lockdown in Italy
Sbarro Health Research Organization (SHRO)

The isolation and abrupt interruption of social contacts and interpersonal affective relationships caused by the Covid-19 pandemic have triggered greater fragility and uncertainty in people and this condition has also had repercussions in the human-dog relationship.

   

Showing results 1 – 50 of 207


close
0.36128